Thalidomide is remembered as one of the worst medical disasters of the 20th century, yet today it sits on the World Health Organization's list of essential medicines, treating aggressive blood cancers and complications of leprosy. This episode follows the molecule's astonishing journey from a soap maker's lab in postwar Germany, through a global tragedy that harmed an estimated 10,000 to 20,000 infants, to its rebirth as a modern miracle drug, and how that journey built the foundation of modern pharmaceutical safety.

We unpack the flawed dogma of the impenetrable placental barrier, the precise developmental window in which the drug caused birth defects, and how Dr. Frances Oldham Kelsey's refusal to approve it spared the United States. We then explore its accidental rediscovery for leprosy, the angiogenesis research that explained its actio ...